See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Akzo Nobel NV (AKZOY) - free report >>
Asahi Kasei Corp. (AHKSY) - free report >>
Barratt Developments PLC Unsponsored ADR (BTDPY) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Akzo Nobel NV (AKZOY) - free report >>
Asahi Kasei Corp. (AHKSY) - free report >>
Barratt Developments PLC Unsponsored ADR (BTDPY) - free report >>
Image: Bigstock
New Strong Sell Stocks for October 12th
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
AkzoNobel (AKZOY - Free Report) is a leading global paints and coatings company and a major producer of specialty chemicals. The Zacks Consensus Estimate for its current year earnings has been revised 17.7% downward over the last 60 days.
Barratt Developments (BTDPY - Free Report) is engaged in the business of developing residential and non-residential properties primarily in the United Kingdom. The Zacks Consensus Estimate for its current year earnings has been revised almost 12.5% downward over the last 60 days.
Asahi Kasei (AHKSY - Free Report) is a provider of innovative solutions based in chemistry and materials science to a diverse range of markets including fibers, chemicals, consumer products, housing, construction, electronics, and health care. The Zacks Consensus Estimate for its current year earnings has been revised 7.7% downward over the last 60 days.
View the entire Zacks Rank #5 List.